Schedule 13G ownership disclosure

BIOTECH ACQUISITION COMPANY

Security class unavailable · CUSIP: G1125A108

Event date: 2023-01-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
405,900
Percent of class
5.3900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-007405
Form type
SC 13G
Filer
Biotech Acquisition Co
CIK
CIK 1825413
Filed
Jan 27, 2023
Reporting period
Jan 25, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub